retatrutide nejm 2023 obesity trial ly3437943 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Retatrutide: Phase 3 Results (Up

Some of the key allegations in the Ozempic lawsuits include the following: Failure to warn and inadequate labeling: Lawsuits contain allegations that Novo Nordisk did not adequately warn Ozempic patients about some of the severe gastrointestinal and vision complications they might experience

When your child takes large oral doses for systemic primary carnitine deficiency (SPCD), some of the supplement is left unabsorbed in the digestive tract

Compounded GLP-1 drugs are versions of GLP-1 medications created by compounding pharmacies rather than manufactured by pharmaceutical companies

What Consumers Should Know About GLP-1 Evidence and FeelGood's Brand-Stated Outcome Claims There are two separate issues consumers should not confuse: the clinical evidence for FDA-approved GLP-1 medications in appropriate patients, and FeelGood's brand-stated outcome claims for its own telehealth program

Food Sources vs Supplements Does L-carnitine burn fat better from food or supplements